Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Pizzorno, Andrés ^a   Dubois, Julia ^a   Machado, Daniela ^a   Cartet, Gaëlle ^a   Traversier, Aurelien ^a   Julien, Thomas ^a   Lina, Bruno ^a,b   Bourdon, Jean Christophe ^c   Rosa Calatrava, Manuel ^a   Terrier, Olivier ^a  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INS1 PROTEIN, INFLUENZA VIRUS; MDM2 PROTEIN, HUMAN; PROTEIN MDM2; PROTEIN P53; UBIQUITIN PROTEIN LIGASE; VIRAL PROTEIN;

CELL LINE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLUENZA; INFLUENZA A VIRUS; METABOLISM; PHYSIOLOGY; PROTEIN STABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; VIROLOGY;

CELL LINE; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; PROTEIN STABILITY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-MDM2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 85042691118     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-22139-6     Document Type: Article

References (41)

1. Paules, C. & Subbarao, K. Influenza. Lancet Lond Engl. https://doi.org/10.1016/S0140-6736(17)30129-0 (2017).
2. Neumann, G. & Kawaoka, Y. The first influenza pandemic of the new millennium. Influenza Other Respir Viruses 5, 157-166 (2011).
3. Fukuyama, S. & Kawaoka, Y. The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr Opin Immunol 23, 481-486 (2011).
4. Stertz, S. & Shaw, M. L. Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes Infect Inst Pasteur 13, 516-525 (2011).
5. König, R. et al. Human host factors required for influenza virus replication. Nature 463, 813-817 (2010).
6. Karlas, A. et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463, 818-822 (2010).
7. Lane, D. & Levine, A. p53 Research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol 2, a000893 (2010).
8. Bieging, K. T., Mello, S. S. & Attardi, L. D. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14, 359-370 (2014).
9. Ludwig, S. & Planz, O. Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy. Biol Chem 389, 1307-1312 (2008).
10. Ehrhardt, C. & Ludwig, S. A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway. Cell Microbiol 11, 863-871 (2009).
11. Turpin, E. et al. Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol 79, 8802-8811 (2005).
12. Zhirnov, O. P. & Klenk, H.-D. Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis Int J Program Cell Death 12, 1419-1432 (2007).
13. Shen, Y. et al. Influenza A virus induces p53 accumulation in a biphasic pattern. Biochem Biophys Res Commun 382, 331-335 (2009).
14. Terrier, O. et al. Cellular transcriptional profiling in human lung epithelial cells infected by different subtypes of influenza A viruses reveals an overall down-regulation of the host p53 pathway. Virol J 8, 285 (2011).
15. Terrier, O. et al. Influenza NS1 interacts with p53 and alters its binding to p53-responsive genes, in a promoter-dependent manner. FEBS Lett 587, 2965-2971 (2013).
16. Terrier, O. et al. Influenza A viruses control expression of proviral human p53 isoforms p53β and Delta133p53α. J Virol 86, 8452-8460 (2012).
17. Ponnuswamy, A., Hupp, T. & Fåhraeus, R. Concepts in MDM2 Signaling. Genes Cancer 3, 291-297 (2012).
18. Park, S.-W. et al. Hantaan virus nucleocapsid protein stimulates MDM2-dependent p53 degradation. J Gen Virol 94, 2424-2428 (2013).
19. Wang, X. et al. Stabilization of p53 in influenza A virus-infected cells is associated with compromised MDM2-mediated ubiquitination of p53. J Biol Chem 287, 18366-18375 (2012).
20. Moulès, V. et al. Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles. Virology 414, 51-62 (2011).
21. Vassilev, L. T. et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848 (2004).
22. Lu, Y. et al. Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy. J Med Chem 49, 3759-3762 (2006).
23. Khoo, K. H., Hoe, K. K., Verma, C. S. & Lane, D. P. Drugging the p53 pathway: understanding the route to clinical efficacy. Nat Rev Drug Discov 13, 217-236 (2014).
24. Henning, W. et al. MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection. J Virol 71, 7609-7618 (1997).
25. Santos, C. R., Vega, F. M., Blanco, S., Barcia, R. & Lazo, P. A. The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism. Virology 328, 254-265 (2004).
26. Haupt, V. J. & Schroeder, M. Old friends in new guise: repositioning of known drugs with structural bioinformatics. Brief Bioinform 12, 312-326 (2011).
27. Zhou, X., Liao, J.-M., Liao, W.-J. & Lu, H. Scission of the p53-MDM2 Loop by Ribosomal Proteins. Genes Cancer 3, 298-310 (2012).
28. Terrier, O. et al. The influenza fingerprints: NS1 and M1 proteins contribute to specific host cell ultrastructure signatures upon infection by different influenza A viruses. Virology 432, 204-218 (2012).
29. Terrier, O. et al. Nucleolin interacts with influenza A nucleoprotein and contributes to viral ribonucleoprotein complexes nuclear trafficking and efficient influenza viral replication. Sci Rep 6, 29006 (2016).
30. Panthu B et al. The NS1 protein from influenza virus stimulates translation initiation by enhancing ribosome recruitment to mRNAs. J Mol Biol, https://doi.org/10.1016/j.jmb.2017.04.007 (2017).
31. Gack, M. U. et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5, 439-449 (2009).
32. Zhang, P. et al. TRIM25 has a dual function in the p53/Mdm2 circuit. Oncogene 34, 5729-5738 (2015).
33. Shin, Y.-K., Liu, Q., Tikoo, S. K., Babiuk, L. A. & Zhou, Y. Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 88, 13-18 (2007).
34. Muñoz-Fontela, C., Mandinova, A., Aaronson, S. A. & Lee, S. W. Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nat Rev Immunol 16, 741-750 (2016).
35. Lazo, P. A. & Santos, C. R. Interference with p53 functions in human viral infections, a target for novel antiviral strategies? Rev Med Virol 21, 285-300 (2011).
36. Bohlman, S. & Manfredi, J. J. p53-independent effects of Mdm2. Subcell Biochem 85, 235-246 (2014).
37. Thomasova, D., Mulay, S. R., Bruns, H. & Anders, H.-J. p53-Independent Roles of MDM2 in NF-κB Signaling: Implications for Cancer Therapy, Wound Healing, and Autoimmune Diseases. Neoplasia N Y N 14, 1097-1101 (2012).
38. Wurzer, W. J. et al. Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 22, 2717-2728 (2003).
39. Moules, V. et al. In vitro characterization of naturally occurring influenza H3NA-viruses lacking the NA gene segment: toward a new mechanism of viral resistance? Virology 404, 215-224 (2010).
40. Juven, T., Barak, Y., Zauberman, A., George, D. L. & Oren, M. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8, 3411-3416 (1993).
41. Xirodimas, D., Saville, M. K., Edling, C., Lane, D. P. & Laín, S. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene 20, 4972-4983 (2001).